Heat Biologics, Inc. (HTBX) financial statements (2022 and earlier)

Company profile

Business Address 627 DAVIS DRIVE
MORRISVILLE, NC 27560
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:96,400111,80014,75427,7009,7637,843
Cash and cash equivalents8,05410,9329,04022,1549,7637,843
Short-term investments88,325100,8425,7145,570  
Other undisclosed cash, cash equivalents, and short-term investments2126 (24)  
Receivables6617735291582
Prepaid expense1,165836253402307 
Other current assets  190109 
Other undisclosed current assets1,7019811485831,552338
Total current assets:99,331113,79415,20928,71411,7458,263
Noncurrent Assets
Property, plant and equipment2,158676559643287360
Intangible assets, net (including goodwill)(2,200)     
Goodwill(2,200)     
Other noncurrent assets19,4719,72410,1888,4078,157274
Other undisclosed noncurrent assets2,200     
Total noncurrent assets:21,63010,40010,7479,0508,444634
TOTAL ASSETS:120,961124,19525,95737,76420,1898,897
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,3422,6663,1802,6533,3101,595
Accounts payable9231,0521,5039751,034290
Accrued liabilities2,4201,6151,6761,6782,2761,305
Deferred revenue 6043,410
Debt261108266   
Business combination, contingent consideration, liability593 1,5791,187  
Deferred revenue and credits7,026 
Other undisclosed current liabilities525279 1,033  
Total current liabilities:4,7213,6578,4354,87210,3361,595
Noncurrent Liabilities
Long-term debt and lease obligation1,3161,4621,662   
Finance lease, liability255160143
Operating lease, liability1,0611,3021,520
Liabilities, other than long-term debt2,3062,9202,7012,4494,072461
Deferred revenue35238200
Deferred tax liabilities, net3171,302 
Deferred income tax liabilities216362362
Other liabilities5436 214161461
Business combination, contingent consideration, liability1,9902,2512,1391,9182,609 
Derivative instruments and hedges, liabilities1134    
Other undisclosed noncurrent liabilities585662 200  
Total noncurrent liabilities:4,2075,0444,3632,6494,072461
Total liabilities:8,9288,70112,7997,52114,4092,057
Stockholders' equity
Stockholders' equity attributable to parent113,108116,23913,57230,2907,3718,797
Common stock557615
Additional paid in capital278,890247,048118,174114,88376,38265,869
Accumulated other comprehensive loss(68)(166)(11)(20)(166)(72)
Accumulated deficit(165,719)(130,647)(104,598)(84,580)(68,846)(57,005)
Stockholders' equity attributable to noncontrolling interest(1,075)(745)(414)(47)(1,590)(1,957)
Total stockholders' equity:112,034115,49413,15830,2435,7816,840
TOTAL LIABILITIES AND EQUITY:120,961124,19525,95737,76420,1898,897

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues2,1132,9483,0495,7941,520342
Revenue, net 342
Gross profit:2,1132,9483,0495,7941,520342
Operating expenses(37,532)(29,072)(23,795)(23,754)(14,863)(13,469)
Operating loss:(35,419)(26,124)(20,746)(17,960)(13,343)(13,127)
Nonoperating income (expense)(128)(257)406384123153
Other nonoperating income (expense)(966)255(26)118101671
Interest and debt expense(22)(18)(1)  (549)
Loss from continuing operations before equity method investments, income taxes:(35,569)(26,399)(20,340)(17,577)(13,219)(13,524)
Other undisclosed income from continuing operations before income taxes22181   
Loss from continuing operations before income taxes:(35,547)(26,381)(20,340)(17,577)(13,219)(13,524)
Income tax expense (benefit)146 (45)985810 
Loss before gain (loss) on sale of properties:(35,401)(26,381)(20,385)(16,591)(12,410)(13,524)
Other undisclosed net income     549
Net loss:(35,401)(26,381)(20,385)(16,591)(12,410)(12,975)
Net income attributable to noncontrolling interest329332367857568401
Net loss available to common stockholders, diluted:(35,071)(26,050)(20,018)(15,734)(11,842)(12,574)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(35,401)(26,381)(20,385)(16,591)(12,410)(12,975)
Other comprehensive income (loss)98(155)9146(94)14
Comprehensive loss:(35,303)(26,536)(20,376)(16,445)(12,504)(12,960)
Comprehensive income, net of tax, attributable to noncontrolling interest329332367857568401
Comprehensive loss, net of tax, attributable to parent:(34,973)(26,205)(20,009)(15,588)(11,935)(12,560)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: